By upregulating oncoproteins associated with resistance to ADT and taxane chemotherapy, activated GR signaling may promote the proliferation and migration of highly aggressive PCa tumor cells with enhanced therapy resistance capabilities. This evidence concerns the gene NR3C1 and neoplasm.